SIOP Europe, the European Society for Paediatric Oncology (SIOPE) shared a post on LinkedIn:
“Big news for EJC Paediatric Oncology!
We are proud to announce that EJC Paediatric Oncology has received its first Journal Impact Factor of 2.0, awarded by Clarivate in the 2026 edition of the Journal Citation Reports (JCR).
This important milestone reflects the quality, impact, and growing influence of the journal since its launch in 2023. It would not have been possible without the outstanding contributions of our authors, editors, reviewers, and the wider paediatric oncology community. Thank you for your continued support.
As we reach the halfway point of 2026, there’s never been a better time to publish with EJC. Whether your work focuses on clinical research, translational science, or reviews, your research will reach an international audience while supporting SIOPE’s mission to improve outcomes for children and young people with cancer.
Submit your manuscript today.”
More posts about SIOP Europe.